(30 days)
Not Found
No
The summary describes a physical guidewire and its materials, with no mention of software, algorithms, or AI/ML capabilities.
No.
The device is a guidewire, intended to facilitate the placement of balloon dilatation catheters, not to provide therapy itself. It is an accessory device used during therapeutic procedures (PTCA/PTA).
No
The device is described as a guidewire intended to facilitate the placement of balloon dilatation catheters, which is a procedural aid rather than a diagnostic tool. Its function is to guide other devices, not to diagnose conditions.
No
The device description clearly outlines physical components (stainless steel, Nitinol core, coil, PTFE coating, hydrophilic coating) and manufacturing processes (packaging, sterilization), indicating it is a hardware medical device, not software-only.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states that the device is used to "facilitate the placement of balloon dilitation catheters during PTCA and/or PTA." This describes a device used within the body for a therapeutic procedure (percutaneous transluminal coronary angioplasty/angioplasty).
- Device Description: The description details the physical construction of a guidewire, including materials, coatings, and packaging. This aligns with a medical device used for navigation within the vasculature.
- Lack of IVD Characteristics: There is no mention of the device being used to examine specimens derived from the human body (like blood, urine, tissue, etc.) to provide information for diagnosis, monitoring, or screening.
IVD devices are specifically designed to perform tests outside the body on biological samples. This device is designed to be used inside the body during a medical procedure.
N/A
Intended Use / Indications for Use
The Modified Radius Cougar Wire is intended to facilitate the placement of balloon dilitation catheters during PTCA and/or PTA. The Modified Radius Cougar Wires are compatible with all currently approved and marketed PTCA balloon catheters which are labeled for use with an 014 guidewire.
Radius Cougar Wire is intended for placement of balloon dilatation catheters during PTCA and/or PTA.
Product codes
DQX
Device Description
The Modified Radius Cougar Wire is constructed from a composite stainless steel and Nitinol core to which a coil is attached to the tapered distal section. The proximal section of the wire is coated with PTFE, and the distal coil portion of the wire is hydrophilic coated. The device is packaged in a protective hoop sealed into a Tyvek/mylar pouch, and is sterilized using ETO gas.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The following in vitro performance tests were performed on the Modified Radius Cougar Wire: 1. Tensile Strength - 2. Accelerated Age Testing - 3. Coating Adherence/Integrity - 4. Biocompatability
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.1330 Catheter guide wire.
(a)
Identification. A catheter guide wire is a coiled wire that is designed to fit inside a percutaneous catheter for the purpose of directing the catheter through a blood vessel.(b)
Classification. Class II (special controls). The device, when it is a torque device that is manually operated, non-patient contacting, and intended to manipulate non-cerebral vascular guide wires, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 870.9.
0
OCT 17 2003
Attachment 6 510(k) Summary of Safety and Effectiveness September 15, 2003
GENERAL INFORMATION A.
Submitter's Name: | Radius Medical Technologies, Inc. | |
---|---|---|
Address: | 15 Craig Road | |
Acton, MA 01720 | ||
Contact Person: | Maureen A. Finlayson | |
Device Generic Name: | PTCA Guidewire | |
Device Trade Name: | Radius Cougar Wire | |
Classification Name: | Wire, Guide, Cardiovascular (74DOX) |
B. INDICATIONS
The Modified Radius Cougar Wire is intended to facilitate the placement of balloon dilitation catheters during PTCA and/or PTA. The Modified Radius Cougar Wires are compatible with all currently approved and marketed PTCA balloon catheters which are labeled for use with an 014 guidewire.
ட் DESCRIPTIVE CHARACTERISTICS
The Modified Radius Cougar Wire is constructed from a composite stainless steel and Nitinol core to which a coil is attached to the tapered distal section. The proximal section of the wire is coated with PTFE, and the distal coil portion of the wire is hydrophilic coated. The device is packaged in a protective hoop sealed into a Tyvek/mylar pouch, and is sterilized using ETO gas.
COMPARATIVE INFORMATION D.
The Modified Radius Cougar Wire is substantially equivalent to the currently marketed Radius PTCA Guidewire (K970466) and the Radius Cougar Wire (K011287).
PERFORMANCE TESTING E.
The following in vitro performance tests were performed on the Modified Radius Cougar Wire: 1. Tensile Strength
-
- Accelerated Age Testing
-
- Coating Adherence/Integrity
-
- Biocompatability
CONCLUSION:
Based on the indications for use, technological characteristics, and safety and performance testing, the proposed modifications to the Radius Cougar Wire meets the minimum requirements that are considered adequate for its intended use.
1
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/1/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features the department's name encircling a symbol. The symbol is a stylized representation of a human figure, with three overlapping profiles suggesting a sense of community or interconnectedness.
OCT 17 2003
Public Health Service
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Radius Medical Technologies, Inc. c/o Ms. Debbie Iampietro 7 Tiffany Trail Hopkinton, MA 01748
Re: K032899
Trade Name: Radius Cougar Wire Regulation Number: 21 CFR 870.1330 Regulation Name: Catheter Guide Wire Regulatory Class: Class II (two) Product Code: DQX Dated: September 15, 2003 Received: September 18, 2003
Dear Ms. Iampietro:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. Ilsting of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act
2
Page 2 – Ms. Debbie Iampietro
or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4646. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Mefan Mup
Bram D. Zuckerman, M.D.
Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
3
510(k) Number (if known): ___________________________________________________________________________________________________________________________________________________
Device Name: Radius Cougar Wire
Indications For Use:
Radius Cougar Wire is intended for placement of balloon dilatation catheters during PTCA and/or PTA.
(PLEASE DO NOT WRITE BELOW THIS LINE. CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE) | ||
---|---|---|
(Division Sign-Off) | ||
Division of Cardiovascular Devices | ||
510(k) Number | K032899 | |
Prescription Use | ||
(Per 21 CFR 801.109) | OR | Over-The-Counter Use |